lumbar disc
-
Spine
BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y.,, April 18, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage…
Read More » -
Biologics
BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
Notice of Allowance Grants Protection for BioRestorative’s Phase 2 Clinical Program to Treat Chronic Lumbar Disc Disease MELVILLE, N.Y., Feb.…
Read More » -
Spine
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company…
Read More » -
Spine
Nocimed Announces Publication of Using Magnetic Resonance Spectroscopy to Identify Painful Lumbar Discs in the European Spine Journal
by Josh Sandberg, August 23, 2019 Nocimed, the leader in the adjunct diagnosis of degenerative disc disease (DDD) pain, has…
Read More » -
Hospitals
Denver Back Pain Specialists Physicians Begin Enrollment in Stem Cell Therapy Study in Subjects with Chronic Back Pain
DENVER, July 27, 2015 /PRNewswire/ — Denver Back Pain Specialists today announced that it has enrolled its first patient in a nationwide…
Read More »